Changes in the plasma cytokine and growth factor profile are associated with impaired healing in pediatric patients...

Area of Science:

• Regenerative Medicine
• Biomarker Discovery
• Wound Healing Research

Background:

• Large skin defects require dermal scaffolds like INTEGRA(®) for reconstruction.
• Infection is a significant complication impacting healing outcomes in these procedures.
• Identifying early biomarkers can improve patient management and graft success.

Purpose of the Study:

• To identify early biomarkers predicting complications during INTEGRA(®) healing.
• To analyze the correlation between specific protein levels and post-operative complications.
• To assess the potential for early intervention based on biomarker data.

Main Methods:

• Measured levels of EGF, TGF-β1, FGF-2, VEGF, IFN-α, GM-CSF, IL-4, and IL-8 in pediatric patients undergoing INTEGRA(®) procedures.
• Collected blood samples pre-surgery and at days 1, 7, and 25 post-surgery.
• Correlated biomarker levels with the occurrence of post-operative complications, specifically local infection.

Main Results:

• A local infection complication occurred in 4 out of 15 patients, reducing INTEGRA(®) take rate.
• Significantly higher plasma concentrations of IL-4 and FGF-2 were observed on day 7 in patients with complications (p=0.037 and p=0.008).
• Other measured markers showed no significant differences; WCC and CRP remained within normal ranges.

Conclusions:

• Elevated IL-4 and FGF-2 levels at day 7 post-surgery may serve as early predictors of complications in INTEGRA(®) healing.
• Early identification of these biomarkers could facilitate timely interventions.
• This research supports proactive management to prevent complications and improve reconstructive surgery outcomes.